The company also believes the transfer to the Mainboard would “enhance its image” and provide it with “greater visibility and recognition in the market”, which is “particularly critical in this Covid-19 pandemic situation”.
Medtecs International says it intends to make an application to transfer its listing from the Catalist to the Mainboard of the Singapore Exchange Securities Trading Limited (SGX-ST) on Nov 16.
The proposed transfer, according to the company, would better place the company to attract institutional investors and reach out to a wider investor base in Singapore and overseas.
